DNAPrint Genomics
DNAG · OTC
$0.00+$0.00 (+0.00%)TodayMarket closed ·
No price history for this range.
Key indicators
DNAG profitability and balance sheet ratios
EPS -$0.003 in Sep 2007, against -$0.0085 a year earlier.
| Period | EPS |
|---|---|
| Dec 2005 | -$0.0214 |
| Mar 2006 | -$0.0098 |
| Jun 2006 | -$0.0067 |
| Sep 2006 | -$0.0085 |
| Dec 2006 | -$0.009 |
| Mar 2007 | $0.0039 |
| Jun 2007 | -$0.003 |
| Sep 2007 | -$0.003 |
Income statement
No financial statements are reported for DNAPrint Genomics.
Balance sheet
What the company owns and owes at period end
Total assets
Total liabilities
| Line item | Mar 2007 | Jun 2007 | Sep 2007 |
|---|---|---|---|
| Total assets | $6.7M | $4.9M | $3.1M |
| Total liabilities | $12.4M | $12.0M | $11.5M |
| Shareholder equity | −$5.8M | −$7.0M | −$8.4M |
| Cash and short-term investments | $0.3M | $0.5M | $0.1M |
| Total debt | $6.3M | $5.9M | $5.5M |
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.